Diabetic retinopathy and vascular endothelial growth factor

Diabetic retinopathy and vascular endothelial growth factor

Bibliographic Details
Main Author:	Majid Khazaei
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2013-01-01
Series:	Journal of Research in Medical Sciences
Online Access:	http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2013;volume=18;issue=6;spage=536;epage=536;aulast=Khazaei

Similar Items

Correlation of vascular endothelial growth factor and microvascular damage in diabetic retinopathy
by: Ji-Quan Wen, et al.
Published: (2015-12-01)

The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy
by: V. Yu. Evgrafov, et al.
Published: (2022-07-01)

Vascular endothelial growth factor inhibitors for retinopathy of prematurity
by: O.V. Zhukova, et al.
Published: (2020-11-01)

Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
by: Jacob Koshy
Published: (2013-01-01)

Relationship between levels of vascular endothelial growth factor in blood and severity of diabetic retinopathy
by: Jebinth Brayan, et al.
Published: (2021-01-01)

Increased levels of vascular endothelial growth factor in the aqueous humor of patients with diabetic retinopathy
by: Selim Kocabora, et al.
Published: (2010-01-01)

Axial myopia, a protective factor for diabetic retinopathy-role of vascular endothelial growth factor
by: Ashish Kulshrestha, et al.
Published: (2022-05-01)

Study of anti-vascular endothelial growth factor medicine for proliferative diabetic retinopathy at perioperative period
by: Mei Sun, et al.
Published: (2015-10-01)

Vascular endothelial growth factor +405G/C polymorphism as a predictor of diabetic retinopathy
by: Azza K. Amer, et al.
Published: (2020-04-01)

Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor
by: Chen-Yuan Gong, et al.
Published: (2013-10-01)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018-08-01)

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?
by: Lihteh Wu, et al.
Published: (2019-01-01)

Angiogenesis in Health and Disease: Role of Vascular Endothelial Growth Factor (VEGF)
by: Ensieh Salehi, et al.
Published: (2011-05-01)

Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy.
by: Ahmed M Abu El-Asrar, et al.
Published: (2013-01-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
by: Irini Chatziralli, et al.
Published: (2021-07-01)

Research of changes in the level of vascular endothelial growth factor in experimental diabetic retinopathy. comparison of methods of correction
by: Ya. Sirman, et al.
Published: (2021-04-01)

Increased levels of vascular endothelial growth factor in aqueous humor of patients with diabetic retinopathy: Is it the whole truth?
by: K S Santhan Gopal
Published: (2011-01-01)

Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy
by: Bahariv, et al.
Published: (2012-01-01)

Progress of anti-vascular endothelial growth factor drugs for the treatment of retinopathy of prematurity
by: Tong Ding, et al.
Published: (2023-08-01)

Prospects for the treatment of diabetic retinopathy: Modulation of endothelial growth factor
by: Anatoliy Gennad'evich Kuzmin, et al.
Published: (2009-06-01)

Vascular endothelial growth factor in the fluid of the anterior chamber of the eye in patients with diabetic retinopathy, cataract andneovascular glaucoma
by: Anatoliy Gennad'evich Kuz'min, et al.
Published: (2010-09-01)

Relationships among Retinal Nonperfusion, Neovascularization, and Vascular Endothelial Growth Factor Levels in Quiescent Proliferative Diabetic Retinopathy
by: Ho Ra, et al.
Published: (2020-05-01)

Application progress of laser photocoagulation in diabetic retinopathy treatment in the era of anti-vascular endothelial growth factor agents
by: Ke-Ke Hu, et al.
Published: (2023-08-01)

Evaluation of vascular endothelial growth factor level in tears and aqueous among patients with non-proliferative diabetic retinopathy
by: Shahrudin, Azima Ahmad
Published: (2022)

Glaucoma Drainage Device Erosions in Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy
by: Islam YFK, et al.
Published: (2022-11-01)

Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation
by: Rami Al-Dwairi, et al.
Published: (2023-11-01)

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
by: Aniket Ramshekar, et al.
Published: (2021-12-01)

Relationships of vascular endothelial growth factor (VEGFA) with stage of diabetic retinopathy and disease duration in patients with type 2 diabetes mellitus
by: A. S. Hudz, et al.
Published: (2018-04-01)

Diabetic macular edema and proliferative diabetic retinopathy treated with anti-vascular endothelial growth factor under the reimbursement policy in Taiwan
by: Ming-Chieh Hsieh, et al.
Published: (2022-01-01)

Effects of intravitreous injection on the expression of vascular endothelial growth inhibitor in vitreous of proliferative diabetic retinopathy
by: Rui Shi, et al.
Published: (2015-06-01)

Characterization of Diabetic Retinopathy in Two Mouse Models and Response to a Single Injection of Anti-Vascular Endothelial Growth Factor
by: Tamar Azrad-Leibovich, et al.
Published: (2022-12-01)

Effect of anti-vascular endothelial growth factor therapy on intraocular inflammatory cytokine levels in the treatment of proliferative diabetic retinopathy
by: Jin-Xiu Luo, et al.
Published: (2023-05-01)

Serum Erythropoietin, Insulin-Like Growth Factor 1 and Vascular Endothelial Growth Factor in Ethiopathogenesis of Retinopathy of Prematurity
by: Özlem Yenice, et al.
Published: (2012-12-01)

Correlation of serum miR-146a with nuclear factor -κB and vascular endothelial growth factor in diabetic retinopathy patients
by: Chui-Ren Zhou, et al.
Published: (2018-08-01)

THE ROLE OF VASCULAR GROWTH FACTORS IN DIABETIC RETINOPATHY AND MACULAR EDEMA DEVELOPMENT
by: A. G. Iskhakova, et al.
Published: (2018-10-01)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
by: Anil Gangwe, et al.
Published: (2021-01-01)

THE EFFECT OF ASPIRIN ON SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AND NITRIC OXIDE CONCENTRATION IN HIGH-CHOLESTEROL FED RABBITS
by: Majid Khazaei, et al.
Published: (2010-12-01)

Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea
by: Hyeon-Jeong Lee, et al.
Published: (2023-12-01)

Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy
by: Kazuhiro Sugimoto, et al.
Published: (2019-09-01)

Relationship between Macular Thickness and the Ratio of Vascular Endothelial Growth Factor to Its Soluble Receptor 1 in Non-Proliferative Diabetic Retinopathy
by: Zahra Hasanpour, et al.
Published: (2012-11-01)